|
Cannabis Campaigners' Guide News Database result:
|
|
UK: Cannabis hopes take GW higher
Martin Barrow The Times
Tuesday 19 Feb 2002 SHARES of GW Pharmaceuticals rose 15p to 146p yesterday amid hopes that its cannabis-based drugs could be available by prescription in Britain within two years. The government-funded Medical Research Council has confirmed that it is testing cannabis-based tablets on hundreds of sufferers of multiple sclerosis (MS). The results of those tests, expected at the end of this year, will be forwarded to the National Institute for Clinical Excellence, the UK's medical watchdog, which will decide whether the tablets should be offered on prescription through the NHS. Cannabis is favoured by many MS and cancer sufferers, who say it kills pain and stimulates appetite without the corrosive side-effects of many prescription alternatives. Yesterday Dr Geoffrey Guy, GW's executive chairman, said: 'This is a positive move by the Government.' The Multiple Sclerosis Society, the UK's largest charity for the 85,000 British people affected by the crippling disorder, said it welcomed any new, safe treatments.
After you have finished reading this article you can click here to go back.
|
This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!